Literature DB >> 25595243

Optimizing the leveraging of real-world data to improve the development and use of medicines.

Marc L Berger1, Craig Lipset2, Alex Gutteridge2, Kirsten Axelsen2, Prasun Subedi2, David Madigan3.   

Abstract

Health research, including health outcomes and comparative effectiveness research, is on the cusp of a golden era of access to digitized real-world data, catalyzed by the adoption of electronic health records and the integration of clinical and biological information with other data. This era promises more robust insights into what works in health care. Several barriers, however, will need to be addressed if the full potential of these new data are fully realized; these will involve both policy solutions and stakeholder cooperation. Although a number of these issues have been widely discussed, we focus on the one we believe is the most important-the facilitation of greater openness among public and private stakeholders to collaboration, connecting information and data sharing, with the goal of making robust and complete data accessible to all researchers. In this way, we can better understand the consequences of health care delivery, improve the effectiveness and efficiency of health care systems, and develop advancements in health technologies. Early real-world data initiatives illustrate both potential and the need for future progress, as well as the essential role of collaboration and data sharing. Health policies critical to progress will include those that promote open source data standards, expand access to the data, increase data capture and connectivity, and facilitate communication of findings.
Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  big data; data access; health policy; health research; real-world data

Mesh:

Substances:

Year:  2014        PMID: 25595243     DOI: 10.1016/j.jval.2014.10.009

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  10 in total

1.  Based Real Time Remote Health Monitoring Systems: A Review on Patients Prioritization and Related "Big Data" Using Body Sensors information and Communication Technology.

Authors:  Naser Kalid; A A Zaidan; B B Zaidan; Omar H Salman; M Hashim; H Muzammil
Journal:  J Med Syst       Date:  2017-12-29       Impact factor: 4.460

2.  Using Electronic Health Record Data to Rapidly Identify Children with Glomerular Disease for Clinical Research.

Authors:  Michelle R Denburg; Hanieh Razzaghi; L Charles Bailey; Danielle E Soranno; Ari H Pollack; Vikas R Dharnidharka; Mark M Mitsnefes; William E Smoyer; Michael J G Somers; Joshua J Zaritsky; Joseph T Flynn; Donna J Claes; Bradley P Dixon; Maryjane Benton; Laura H Mariani; Christopher B Forrest; Susan L Furth
Journal:  J Am Soc Nephrol       Date:  2019-11-15       Impact factor: 10.121

3.  Use of algorithms for identifying patients in a German claims database: learnings from a lung cancer case.

Authors:  Sina Neugebauer; Frank Griesinger; Sabine Dippel; Stephanie Heidenreich; Nina Gruber; Detlef Chruscz; Sebastian Lempfert; Peter Kaskel
Journal:  BMC Health Serv Res       Date:  2022-06-28       Impact factor: 2.908

4.  Big Data: transforming drug development and health policy decision making.

Authors:  Demissie Alemayehu; Marc L Berger
Journal:  Health Serv Outcomes Res Methodol       Date:  2016-03-05

5.  Optimal cumulative cisplatin dose in nasopharyngeal carcinoma patients receiving additional induction chemotherapy.

Authors:  Jia-Wei Lv; Zhen-Yu Qi; Guan-Qun Zhou; Xiao-Jun He; Yu-Pei Chen; Yan-Ping Mao; Lei Chen; Ling-Long Tang; Wen-Fei Li; Ai-Hua Lin; Jun Ma; Ying Sun
Journal:  Cancer Sci       Date:  2018-01-31       Impact factor: 6.716

Review 6.  Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.

Authors:  S D Shorvon; E Trinka; B J Steinhoff; M Holtkamp; V Villanueva; J Peltola; E Ben-Menachem
Journal:  J Neurol       Date:  2017-01-18       Impact factor: 4.849

7.  Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?

Authors:  Sajan Khosla; Robert White; Jesús Medina; Mario Ouwens; Cathy Emmas; Tim Koder; Gary Male; Sandra Leonard
Journal:  F1000Res       Date:  2018-01-25

8.  Concordance of real-world versus conventional progression-free survival from a phase 3 trial of endocrine therapy as first-line treatment for metastatic breast cancer.

Authors:  Cynthia Huang Bartlett; Jack Mardekian; Matthew James Cotter; Xin Huang; Zhe Zhang; Christina M Parrinello; Ariel Bulua Bourla
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

9.  Utilisation of real-world data from heart failure registries in OECD countries - A systematic review.

Authors:  Xiaoyang Du; Adina Khamitova; Mattias Kyhlstedt; Sun Sun; Mathilde Sengoelge
Journal:  Int J Cardiol Heart Vasc       Date:  2018-03-09

10.  The Experience of Establishing Data Sharing & Linkage Platforms for Administrative, Research and Community-Service Data.

Authors:  Kiran Pohar Manhas; Xinjie Cui; Suzanne C Tough
Journal:  Int J Popul Data Sci       Date:  2019-02-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.